0001192482-20-000337.txt : 20200511 0001192482-20-000337.hdr.sgml : 20200511 20200511170340 ACCESSION NUMBER: 0001192482-20-000337 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200507 FILED AS OF DATE: 20200511 DATE AS OF CHANGE: 20200511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berelowitz Michael CENTRAL INDEX KEY: 0001493383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 20865872 MAIL ADDRESS: STREET 1: 415 EAST 37TH STREET STREET 2: APT 36C CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-05-07 0001588972 Recro Pharma, Inc. REPH 0001493383 Berelowitz Michael C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 1 0 0 0 Common Stock 2020-05-07 4 A 0 8363 0 A 49623 D Stock Option (right to buy) 8.37 2020-05-07 4 A 0 12405 0 A 2030-05-07 Common Stock 12405 12405 D All shares of common stock are represented by unvested restricted stock units that will vest on May 7, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date. The stock option will vest on May 7, 2021. /s/ Ryan Lake, Attorney-in-fact 2020-05-11